+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Trial Supply & Logistics Market by Services, Sourcing Model, Type, Mode of Delivery, End-user, Therapeutic Area, Phases of Clinical Trials - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470856
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Trial Supply & Logistics Market grew from USD 24.33 billion in 2023 to USD 26.20 billion in 2024. It is expected to continue growing at a CAGR of 7.75%, reaching USD 41.04 billion by 2030.

The clinical trial supply and logistics sector is at a pivotal juncture, where precision, coordination, and compliance are paramount for the successful execution of studies. With the increasing complexity of clinical trials, operators must navigate stringent regulatory requirements, evolving patient needs, and heightened expectations for transparency and efficiency. This introduction outlines the expanse of the market, detailing the critical intersection of operational excellence and innovative supply chain solutions that are essential for managing clinical trial materials globally.

In today’s environment, the integrity of trial supplies is just as important as the scientific outcomes they help generate. Complex logistics involving procurement, inventory management, and the distribution of experimental drugs and devices have become central to clinical trial success. As the market moves towards more data-driven and patient-centric models, industry stakeholders find themselves compelled to adopt robust systems and advanced technologies. Understanding these dynamics is fundamental for stakeholders who need to ensure timely supplies while adhering strictly to quality and compliance standards in order to support both early and late-phase clinical trial demands.

Transformative Shifts Shaping the Clinical Trials Market

The landscape of clinical trial supply and logistics has undergone unprecedented transformations. Over the past few years, the industry has seen a marked shift towards integrating digital technology and automation across multiple operational layers. Strategic moves to incorporate real-time tracking and transparency have ensured that supply chains are more agile, responsive, and capable of handling the intricacies of a global clinical operations network.

Digital transformations have spurred developments such as advanced inventory management systems and proactive risk mitigation strategies. Changes in regulations worldwide have also forced organizations to re-examine and update their protocols to accommodate new compliance frameworks. The reliance on cloud solutions and integrated data platforms has improved visibility into supply chain performance, leading to shorter lead times and a reduction in operational waste. Furthermore, the push for sustainability and ethical practices has initiated a dialogue around the environmental impact of logistics. In addition to enhanced efficiency and cost management, stakeholders are now also evaluating how to best address environmental concerns without compromising on the quality and timeliness of clinical supplies.

These transformative shifts are not only redefining operational benchmarks but also setting the stage for a more resilient, technology-driven future in clinical trial supply management.

Key Segmentation Insights in Clinical Trial Operations

A thorough understanding of the market segmentation is crucial to addressing the multifaceted needs of clinical trial supply and logistics. The segmentation based on services reveals that the market is evaluated across several functions: comparator sourcing, logistics and distribution, manufacturing, packaging, labeling, blinding, and storage and retention, with logistics and distribution further dissected into cold chain distribution and non-cold chain distribution approaches. These distinctions illustrate the breadth and depth of services required to support modern clinical trials.

Moving into the sourcing model, market studies differentiate between centralized sourcing and decentralized sourcing. This differentiation not only highlights various operational efficiencies but also underscores the strategic trade-offs between control and flexibility. The segmentation based on type divides the market into biologic drugs, medical devices, and small molecules, each with unique handling and storage requirements. Moreover, the mode of delivery segmentation emphasizes the importance of managing supplies effectively, with studies covering both offsite and onsite supply management strategies.

Further segmentation by end-user sheds light on the specific needs of contract research organizations, medical device companies, and pharmaceutical and biotechnology companies. Therapeutic area segmentation provides insights into the challenges and logistics intricacies spanning disciplines such as blood disorders, cardiovascular diseases, central nervous system and mental disorders, dermatological conditions, digestive and ENT diseases, immunology, infectious diseases, metabolic disorders, nephrology, oncology, rare diseases, and respiratory disorders. Lastly, the segmentation based on the phases of clinical trials - from BA/BE studies through Phase 1 to Phase 4 - reflects the evolving supply requirements at every stage of the clinical journey, portraying a comprehensive landscape of the industry's segmented dynamics.

Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.

Based on Sourcing Model, market is studied across Centralized Sourcing and Decentralized Sourcing.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Mode of Delivery, market is studied across Offsite Supply Management and Onsite Supply Management.

Based on End-user, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.

Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.

Based on Phases of Clinical Trials, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.

Regional Trends Influencing Global Operations

The clinical trial supply and logistics ecosystem exhibits significant regional nuances that impact strategic decision-making. The Americas continue to be a robust market characterized by advanced regulatory frameworks, strong infrastructure, and a willingness to adopt innovative technologies. Observations in this region provide insight into high standards of operational performance and the ability to handle complex, large-scale trials.

In contrast, the Europe, Middle East & Africa region offers a mix of mature markets and emerging opportunities, influenced by diverse regulatory environments and varying degrees of technological adoption. The evolution in these regions underscores the need for tailored logistic solutions that can adapt to differing market maturity and healthcare priorities. The Asia-Pacific region, with its rapid economic growth and increasing investments in healthcare innovation, is emerging as a pivotal hub. This region’s fast-paced expansion and growing emphasis on quality and efficiency create fertile ground for innovations that bridge traditional practices with modern technological solutions.

These regional insights reveal how varying market dynamics and infrastructural developments continue to shape the global landscape of clinical trial supply and logistics, prompting stakeholders to consider localized strategies within a globally integrated framework.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Innovative Leadership: Key Companies Reshaping the Market

The dynamic nature of the clinical trial supply and logistics market is driven by a host of leading companies that are continuously pushing the boundaries of operational efficiency and technological integration. Prominent players such as Acnos Pharma GmbH and ADAllen Pharma Ltd are recognized for their specialized approaches in managing complex trial supplies. Organizations like Almac Group Limited and Ancillare, LP are redefining standards with their integrated supply solutions, while Avantor, Inc. and Beroe Holdings Inc. have become synonymous with robust logistical support in high-stakes environments.

The landscape is further enriched by innovators including Biocair International Limited, Calyx, and Catalent, Inc., whose services cater to a spectrum of clinical operations. Clinical Services International LTD and Clinigen Group PLC have consistently provided reliable and adaptive supply chain solutions that align with rapidly evolving trial protocols. COREX LOGISTICS LIMITED, DHL Group, and Eurofins Scientific SE are setting benchmarks in the transport and quality assurance domains, demonstrating their commitment to timely and secure supply chain management. The technological integration spearheaded by companies like Experic, LLC and FedEx Corporation has revolutionized end-to-end visibility.

ICON PLC, Inceptua S.A., and Infosys Limited have successfully merged digital innovations with logistics processes, emphasizing efficiency and data-driven decision-making. Not to be overlooked, key industry contributors such as IPS Pharma, KLIFO A/S, Lonza Group AG, and Marken Limited by United Parcel Service, Inc. have been at the forefront of implementing state-of-the-art solutions. Microsoft Corporation’s capabilities in leveraging cloud and AI-driven analytics and the strategic contributions of Myonex, Inc., N-SIDE SA, and NUVISAN GmbH underscore a market that thrives on technological convergence. The industry continues to evolve with critical insights from OCT Clinical GmbH, Octalsoft, and Parexel International Corporation, alongside specialized service providers like PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG. The expertise of Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited further supports a resilient, forward-thinking market that is adaptable to global clinical trials in an ever-changing healthcare environment.

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Actionable Recommendations for Industry Leaders

Drawing from current trends and multifaceted market segmentation, industry leaders are encouraged to adopt multiple strategic initiatives. First, embracing integrated digital systems to streamline communications, ensure real-time tracking, and automate critical supply processes can significantly reduce lead times and enhance overall efficiency. It is advisable to invest in technologies that provide end-to-end visibility of supply chains, which can help preempt potential disruptions and ensure compliance with evolving regulatory requirements.

Leaders should also consider the benefits of flexible sourcing models. By evaluating the merits of centralized versus decentralized sourcing, organizations can design bespoke solutions that meet the specific demands of their trial phases. It is also crucial to fine-tune logistics strategies, especially in managing cold chain requirements versus conventional distribution, to cater to the unique needs of biologic drugs and other sensitive trial materials.

Moreover, industry innovators are advised to build collaborative relationships with key global partners. This cooperation not only fosters knowledge exchange but also enables co-development of advanced logistics solutions that accommodate regional variances. Strategic focus on training and development, coupled with investment in sustainable practices, can drive both operational excellence and environmental stewardship. These recommendations offer a roadmap for creating resilient supply chains that are capable of navigating the complexities of modern clinical trials, thereby securing a competitive edge in a rapidly evolving market.

Shaping the Future of Clinical Trial Supply & Logistics

In conclusion, the clinical trial supply and logistics sector is undergoing significant change. The convergence of digital innovation, precise segmentation, and strategic regional insights is crafting a future where efficiency, compliance, and agile operations can coexist. With the interplay of meticulous planning and technological advancements, organizations are better equipped to handle the dynamic environment of clinical trials.

This evolving ecosystem not only demands higher standards of accountability and precision but also rewards those who adapt with forward-thinking strategies. By aligning operational practices with innovative supply chain solutions and a comprehensive understanding of the market, leaders can sustainably drive success. The outlook remains promising, with proactive initiatives setting the stage for the next wave of growth and optimization in clinical trial logistics.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Globalization of clinical trials and harmonization of regulations
5.1.1.2. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
5.1.2. Restraints
5.1.2.1. Problems associated with technology integration and data management
5.1.3. Opportunities
5.1.3.1. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
5.1.3.2. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
5.1.4. Challenges
5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
5.2. Market Segmentation Analysis
5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
5.2.3. Mode of Delivery: Growing adoption of offsite solutions for multi-site trials delivery
5.2.4. Sourcing Model: Rising demand for decentralized sourcing models to enhance the speed and efficiency of supply distribution
5.2.5. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
5.2.6. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
5.2.7. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Clinical Trial Supply & Logistics Market, by Services
6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
6.3.1. Cold Chain Distribution
6.3.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention
7. Clinical Trial Supply & Logistics Market, by Sourcing Model
7.1. Introduction
7.2. Centralized Sourcing
7.3. Decentralized Sourcing
8. Clinical Trial Supply & Logistics Market, by Type
8.1. Introduction
8.2. Biologic Drugs
8.3. Medical Devices
8.4. Small Molecules
9. Clinical Trial Supply & Logistics Market, by Mode of Delivery
9.1. Introduction
9.2. Offsite Supply Management
9.3. Onsite Supply Management
10. Clinical Trial Supply & Logistics Market, by End-user
10.1. Introduction
10.2. Contract Research Organisations
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology Companies
11. Clinical Trial Supply & Logistics Market, by Therapeutic Area
11.1. Introduction
11.2. Blood Disorders
11.3. Cardiovascular Diseases
11.4. CNS & Mental Disorders
11.5. Dermatological Disorders
11.6. Digestive Disorders
11.7. ENT Diseases
11.8. Immunology
11.9. Infectious Diseases
11.10. Metabolic Disorders
11.11. Nephrology
11.12. Oncology
11.13. Rare Diseases
11.14. Respiratory Disorders
12. Clinical Trial Supply & Logistics Market, by Phases of Clinical Trials
12.1. Introduction
12.2. BA/ BE studies
12.3. Phase 1
12.4. Phase 2
12.5. Phase 3
12.6. Phase 4
13. Americas Clinical Trial Supply & Logistics Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Clinical Trial Supply & Logistics Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. Catalent strengthens European supply chain with USD 25 million expansion of Schorndorf facility, enhancing FastChain capabilities
16.3.2. Experic strategically expands to Europe with a new Dublin facility enhancing global clinical trial supply and logistics services
16.3.3. FedEx fortifies its global clinical trial logistics with a new life science center in Mumbai, enhancing healthcare supply chain connectivity
16.3.4. PCM Trials acquires Netherlands-based clinical trial service
16.3.5. Piramal Pharma solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland
16.3.6. Biocair announces the U.S. expansion as part Of global growth strategy
16.3.7. Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs
16.3.8. Piramal Pharma Solutions launches in-vitro biology capabilities at Ahmedabad discovery services site
16.3.9. Signant Health Launches Signant Biotech to accelerate and streamline clinical development for emerging biopharmaceutical organizations
16.3.10. N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management
16.3.11. Zuellig Pharma and GSK establish a vaccine distribution hub in Singapore
16.3.12. Ariceum Therapeutics and Eurofins CDMO sign a pharmaceutical multi-project agreement
16.3.13. Vial announces strategic partnership with Royale International Group
16.3.14. Biocair partners with TrakCel to improve visibility in the supply chain
16.3.15. IDEAYA expands clinical trial collaboration and supply agreements with Pfizer
16.3.16. Calyx introduces new clinical trial supply forecasting service
16.3.17. Catalent completes expansion of Singapore clinical supply facility for increased temperature-controlled capabilities
16.4. Strategy Analysis & Recommendation
16.4.1. Almac Group Limited
16.4.2. Catalent, Inc.
16.4.3. DHL Group
16.4.4. Walden Group
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
FIGURE 4. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2030 (%)
FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 30. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 31. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DECENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY OFFSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 78. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 117. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 119. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 120. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 122. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 125. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 127. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 128. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 130. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 132. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 141. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 143. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 144. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 146. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 189. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 191. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 192. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 194. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 214. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 217. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 219. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 229. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 230. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 231. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 232. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 233. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 235. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 237. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 240. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 241. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 245. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 246. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 247. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 248. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 249. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 251. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 253. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 262. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 263. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 264. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 265. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 267. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 269. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 286. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 288. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 289. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 291. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 293. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 294. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 295. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD

Companies Mentioned

  • Acnos Pharma GmbH
  • ADAllen Pharma Ltd
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Calyx
  • Catalent, Inc.
  • Clinical Services International LTD
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • DHL Group
  • Eurofins Scientific SE
  • Experic, LLC
  • FedEx Corporation
  • ICON PLC
  • Inceptua S.A.
  • Infosys Limited
  • IPS Pharma
  • KLIFO A/S
  • Lonza Group AG
  • Marken Limited by United Parcel Service, Inc.
  • Microsoft Corporation
  • Myonex, Inc.
  • N-SIDE SA
  • NUVISAN GmbH
  • OCT Clinical GmbH
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Limited
  • Recipharm AB
  • SAP SE
  • Sharp Services, LLC
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc.
  • Tower Cold Chain Solutions
  • Uniphar PLC
  • Walden Group
  • Zuellig Pharma Pte Ltd by Interpharma Investments Limited

Methodology

Loading
LOADING...

Table Information